Outcome of patients with metastatic colorectal cancer depends on the primary tumor site (midgut vs. hindgut): Analysis of the FIRE1-trial (FuFIRI or mIROX as first-line treatment)
作者:
Modest,D.P. [1]
;
Schulz,C. [2]
;
VonWeikersthal,L.F. [3]
;
Quietzsch,D. [4]
;
VonEinem,J.C. [5]
;
Schalhorn,A. ;
Vehling-Kaiser,U. ;
Laubender,R.P. ;
Giessen,C. ;
Stintzing,S. ;
Heinemann,V.
作者单位:
Onkologische Praxis Landshut, Landshut, Germany
[1]
Department of Medicine III, University Hospital Grosshadern, University of Munich
[2]
Klinikum St Marien Amberg, Germany
[3]
Institute of Medical Informatics, Biometry and Epidemiology, University of Munich, Munich, Germany
[4]
Klinikum Chemnitz, Chemnitz, Germany
[5]
期刊:
《Anti-cancer drugs》
2014年25卷2期212-218页
发布时间:
2014-05-07
- 翻译满意度评价:
- 提交
- 浏览:0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文